Speakers
Leona Bessonova
Director - HEOR
Alkermes
Day One
TUESDAY, SEPTEMBER 29
11:15 am | Opportunities for Patient Perspective Research Supporting Drug Development Lifecycle
9:00 am | Panel: Determining Where Value Lies in RWE
Michael Doane
Manager - HEOR
Alkermes
Day One
TUESDAY, SEPTEMBER 29
11:15 am | Opportunities for Patient Perspective Research Supporting Drug Development Lifecycle
Cathy Critchlow
Vice President, Center for Observational Research
Amgen
Day One
TUESDAY, SEPTEMBER 29
5:15 pm | Chair’s Closing Remarks & End of Day 1
8:50 am | Chair’s Opening Remarks
Day Two
WEDNESDAY, SEPTEMBER 30
4:00 pm | Chair’s Closing Remarks & End of Conference
9:45 am | Strategic Vision for RWE Generation Across the Product Lifecycle
8:55 am | Chair’s Opemimg Remarks
Glynn Dennis
Senior Director of Data Science
AstraZeneca
Day Two
WEDNESDAY, SEPTEMBER 30
11:30 am | Considerations for integrating digital and sensor data into the RWD ecosystem
Maarten Beekman
Respiratory Medical Director, International Region
AstraZeneca
Day One
TUESDAY, SEPTEMBER 29
4:15 pm | Case Study: RWE Global Opportunities & Emerging Markets
9:00 am | Panel: Determining Where Value Lies in RWE
David Anstatt
Executive Director, Center for Observational Research & Data Sciences
Bristol-Myers Squibb
Day One
TUESDAY, SEPTEMBER 29
2:45 pm | Understanding the Global RWE Regulatory Landscape
Day Two
WEDNESDAY, SEPTEMBER 30
9:00 am | Panel: Integration Within the Pharmaceutical Community
Dan Ollendorf
Director, Value Measurement & Global Health Initiatives
Center for the Evaluation of Value and Risk in Health (CEVR)
Day One
TUESDAY, SEPTEMBER 29
4:45 pm | Setting Standards for RWE in Comparative Effectiveness Research: Methods, Transparency & Governance
Angela Dobes
Vice President, IBD Plexus
Crohn’s & Colitis Foundation
Day One
TUESDAY, SEPTEMBER 29
2:15 pm | Identifying Gaps in Current Patient Care Partnering to Accelerate Patient-Centric Real-World Evidence
9:00 am | Panel: Determining Where Value Lies in RWE
Dan Hennessy
Vice President, Medical Affairs
EMD Serono
Day One
TUESDAY, SEPTEMBER 29
1:45 pm | Interweaving RWE into the Strategic Fiber of Therapeutic Areas
9:00 am | Panel: Determining Where Value Lies in RWE
Tehseen Salimi
Vice President of Medical Affairs and Real World Evidence
G1 Therapeutics
Day One
TUESDAY, SEPTEMBER 29
9:45 am | Strategies for Leveraging Real World Data to Support Early Development and Value Proposition for Successful Product Launch
Francis Campion
Principal Lead
MITRE
Day Two
WEDNESDAY, SEPTEMBER 30
10:15 am | Synthea: Augmenting RWD & Synthetic Data into a Limitless Platform
Jason Walonoski
Department Head
MITRE
Day Two
WEDNESDAY, SEPTEMBER 30
10:15 am | Synthea: Augmenting RWD & Synthetic Data into a Limitless Platform
Patricia Schepman
Director, Global HEOR
Pfizer
Day One
TUESDAY, SEPTEMBER 29
3:45 pm | RWE Pre & Post Launch Elements
Sheena Thakkar
Manager, Global HEOR
Pfizer
Day One
TUESDAY, SEPTEMBER 29
3:45 pm | RWE Pre & Post Launch Elements
Miriam Fenton
Director, Real World Investigator
Sanofi
Day Two
WEDNESDAY, SEPTEMBER 30
12:00 pm | Strategic alignment of the question to the data
Frida Schain
CEO & Founder
Schain Research
Day One
TUESDAY, SEPTEMBER 29
9:00 am | Panel: Determining Where Value Lies in RWE
Day Two
WEDNESDAY, SEPTEMBER 30
2:00 pm | Strategizing Market Access - Ensuring Implementation for the Whole of the Drug Development Continuum
Amy Place
Senior Director, Field Medical Affairs
Scholar Rock
Day Two
WEDNESDAY, SEPTEMBER 30
3:00 pm | Global Medical Affairs (GMA): Lessons Learnt from Creating a Department
Javier Jimenez
Executive VP RWE & Late Phase
Syneos Health
Day One
TUESDAY, SEPTEMBER 29
11:45 am | How to Use RWE to Better Define Trial Protocol: Syneos’s Case Studies
Michael Lees
Head of Value, Evidence and Portfolio Strategy
Takeda
Day Two
WEDNESDAY, SEPTEMBER 30
9:00 am | Panel: Integration Within the Pharmaceutical Community
Ipek Stillman
Head Globak Health Economics
Takeda
Thomas Kristensen
Global Health Economics Lead Takeda
Takeda
Day One
TUESDAY, SEPTEMBER 29
12:15 pm | RWE and Patient Advocacy – Patient Centricity
Michael Lacey
Global Health Economics Lead
Takeda
Day One
TUESDAY, SEPTEMBER 29
12:15 pm | RWE and Patient Advocacy – Patient Centricity
Kevin Francis
Principal - Head of RWE, Insights & Analytics
Trinity
Day Two
WEDNESDAY, SEPTEMBER 30
1:30 pm | What is Normal? Using AI to Normalize & Control the Quality of Data Outputs
Omar Ali
Pharmacist Consultant
QIPP Adviser Payer Network
Day Two
WEDNESDAY, SEPTEMBER 30
3:30 pm | Understanding Market Access Methodology
Eric Klein
Senior Director, Oncology - Global Patient Outcomes and RWE
Eli Lilly and Company
Day Two
WEDNESDAY, SEPTEMBER 30
9:00 am | Panel: Integration Within the Pharmaceutical Community
